IFNB1 and myeloid sarcoma: Immune therapies used to treat MS may also a have a role as evidence for a migraine-inducing role of interferon beta exists [24], however, immune therapies could only ever provide a small part of the complete explanation due to the fact that migraine often precedes MS.